Show notes
Host Max Beairsto interviews Peter Saad of Loopstra Nixon LLP about avoiding costly mistakes before closing a pharmacy acquisition. Saad emphasizes that early decisions—NDA disclosures, LOI terms, financing strategy, lease review, diligence, and transaction structure—often determine success more than the final purchase agreement. He warns against “re-trading,” encourages locking key variables in the LOI (e.g., normalized earnings), and highlights common blind spots such as leases, including option terms that affect loan amortization, exclusivity language, demolition clauses, condo…
Website: pharmacy-edge.captivate.fm

